Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (421-430 of 759) with videos related to

Pageof 76
Sort By:
Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.
Blood Advances|December 18, 2024
Cumulative deficits frailty index and relationship status predict survival in multiple myelomaNadine Abdallah, Paul Dizona, Amanika Kumar, et al.
Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75M Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Cancer|May 5, 2016
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Advances|April 5, 2018
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2018
Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain AmyloidosisM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.
Transplantation and Cellular Therapy|May 13, 2022
Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell TransplantSurbhi Sidana, Amylou C Dueck, Gita Thanarajasingam, et al.
JAMA Cardiology|September 7, 2022
A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection FractionDaniel R Davies, Margaret M Redfield, Christopher G Scott, et al.
Pageof 76

Showing results (421-430 of 759) with videos related to

Sort By:
Pageof 76
Blood Cancer Journal|September 23, 2021
The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM)Matthew Ho, Saurabh Zanwar, Prashant Kapoor, et al.
Blood Advances|December 18, 2024
Cumulative deficits frailty index and relationship status predict survival in multiple myelomaNadine Abdallah, Paul Dizona, Amanika Kumar, et al.
Blood Advances|December 5, 2024
Prognostic impact of patient-reported symptoms in multiple myelomaNadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2018
Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75M Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Cancer|May 5, 2016
Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Advances|April 5, 2018
Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantationM Hasib Sidiqi, Mohammed A Aljama, Eli Muchtar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2018
Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain AmyloidosisM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2009
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidneyMorie A Gertz, Nelson Leung, Martha Q Lacy, et al.
Transplantation and Cellular Therapy|May 13, 2022
Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell TransplantSurbhi Sidana, Amylou C Dueck, Gita Thanarajasingam, et al.
JAMA Cardiology|September 7, 2022
A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection FractionDaniel R Davies, Margaret M Redfield, Christopher G Scott, et al.
Pageof 76